Retinoblastoma (Rb) is the most common primary intraocular malignancy of childhood, but
an uncommon paediatric cancer, with a constant incidence worldwide of 1: 15,000–1 …

Retinoblastoma is lethal by metastasis if left untreated, so the primary goal of therapy is to
preserve life, with ocular survival, visual preservation and quality of life as secondary aims …

PURPOSE: To evaluate the reliability of the International Classification of Retinoblastoma
(ICRB) for predicting treatment success with chemoreduction (CRD). DESIGN …

Progress has been made in the past few years in the management of retinoblastoma with
better enucleation implants, chemoreduction-prevention of pinealoblastoma and excellent …

In this report, we explore retinoblastoma diagnostic accuracy and review chemotherapy
alternatives for retinoblastoma using intravenous, intra-arterial, periocular, and intravitreal …

Abstract Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery
chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment …

Current Opinion in Ophthalmology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

PURPOSE: To report the success rate, adverse events, and long-term prognosis of selective
ophthalmic arterial injection (SOAI) therapy for intraocular retinoblastoma. DESIGN …

After completion of this article, the reader will be able to 1) state the therapeutic interventions
that are currently used to treat intraocular retinoblastoma, and to outline the mechanism of …

Background Survivors of heritable retinoblastoma carry a high risk to develop second
cancers. Eye‐preserving radiotherapy raises this risk, while the impact of chemotherapy …